9 studies found for:    Obstetric AND Stanford | Recruiting
Show Display Options
Rank Status Study
1 Recruiting Indomethacin Versus Nifedipine for Preterm Labor Tocolysis
Condition: Obstetric Labor, Premature
Interventions: Drug: Indomethacin;   Drug: Nifedipine
2 Recruiting Effects of Oral Probiotic Supplementation on Group B Strep (GBS) Rectovaginal Colonization in Pregnancy
Conditions: Infection;   Pregnancy
Interventions: Dietary Supplement: Placebo;   Dietary Supplement: Probiotic dietary supplement
3 Unknown  Reading in Preterm and Full-term Children: Neural Basis and Prediction
Conditions: Premature Birth;   Basic Learning Problem in Reading;   Child
Intervention:
4 Recruiting Improving Maternal and Child Health in India: Evaluating Demand and Supply Side Strategies (IMATCHINE)
Conditions: Obstetric Labor Complications;   Post-partum Hemorrhage;   Sepsis;   Pre-eclampsia;   Neonatal Mortality
Interventions: Other: Experimental: Treatment 1;   Other: Experimental: Treatment 2
5 Recruiting The Effect of Fatigue on the Clinical Performance
Condition: Fatigue
Interventions: Other: Fatigued;   Other: Rested
6 Recruiting Oxytocin Infusions and Blood Loss in Patients Undergoing Elective Cesarean Delivery.
Condition: Postpartum Hemorrhage
Intervention: Drug: Oxytocin Infusion
7 Recruiting Magnesium Sulfate vs Placebo for Placental Abruption
Condition: Abruptio Placentae
Interventions: Drug: Magnesium Sulfate;   Other: Normal Saline
8 Recruiting Carboplatin, Paclitaxel and Gemcitabine With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer
Conditions: Brenner Tumor;   Fallopian Tube Cancer;   Ovarian Clear Cell Cystadenocarcinoma;   Ovarian Endometrioid Adenocarcinoma;   Ovarian Mixed Epithelial Carcinoma;   Ovarian Mucinous Cystadenocarcinoma;   Ovarian Serous Cystadenocarcinoma;   Ovarian Undifferentiated Adenocarcinoma;   Primary Peritoneal Cavity Cancer;   Recurrent Ovarian Epithelial Cancer
Interventions: Drug: paclitaxel;   Drug: docetaxel;   Drug: carboplatin;   Biological: bevacizumab;   Drug: gemcitabine hydrochloride;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment
9 Recruiting Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IIIA Endometrial Carcinoma;   Stage IIIB Endometrial Carcinoma;   Stage IIIC Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: paclitaxel;   Drug: carboplatin;   Drug: metformin hydrochloride;   Other: placebo;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment;   Other: questionnaire administration

Indicates status has not been verified in more than two years